Castuner

CEConversations

Creative Educational Concepts

Welcome to CEConversations, a clinical podcast presented by Creative Educational Concepts designed to improve clinician performance and optimize patient outcomes.

Strona podcastu

Słuchaj w swojej aplikacji

Odcinki

49 odcinków

  1. Webcast Finding the Right Rhythm: Supporting Pediatric Oncology Nurses in Longitudinal NF1 Management 56:28
  2. Webcast: Rare, Complex, and Under-Recognized: Supporting Oncology Nurses in the Care of Patients with NF1 52:25
  3. A CaseWise™ Webcast: From Research to Real-World: ADCs, IO Combinations, and Sequencing in Metastatic NSCLC 1:07:45
  4. Exploring the Horizons in Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions for New Treatment Strategies 1:04:47
  5. Targeting the Pathway: Evolving Roles of MEK Inhibitors in NF1-Associated PN 1:04:25
  6. Evolving Paradigms in Immuno-Oncology: Optimizing Patient Care Through Innovative Delivery Approaches of Immune Checkpoint Inhibitors 32:12
  7. The New Era of Hemophilia Treatment 45:41
  8. MEK Inhibitors in Neurofibromatosis Type 1: Nursing Contributions to NF1-PN Management 1:04:33
  9. Desmoid Tumors in Focus: Early Recognition, Evolving Therapies, and Nursing-Led Care Strategies 54:51
  10. The MEKtrix: Decoding the Real-World Impact of Therapeutic Advances in Neurofibromatosis Type 1–Associated Plexiform Neurofibroma Management Across Pediatric and Adult Populations 1:32:45
  11. Emergency Care of Patients with Cancer Receiving CAR T-cell and Bispecific Antibody Immunotherapies Experiencing Serious Adverse Events 47:28
  12. Treating Metastatic HER2-negative Breast Cancer: Oncology Nursing Approaches to Improve Patient Quality of Life 49:37
  13. Advancing Cervical Cancer Care: Navigating New Therapies, Guidelines, and Patient-Centric Approaches 48:09
  14. MEK Inhibitors in Neurofibromatosis Type 1: Latest Advances and Real-World Applications in NF1-PN Management 1:03:44
  15. All Hands on Deck: Spotlight on Clinical Advances in Relapsed/Refractory Diffuse Large B-Cell Lymphoma 51:06
  16. Advancements in the Management of Relapsed/Refractory B-Cell Malignancies – Integrating Recent Data into Practice to Improve Outcomes 51:52
  17. All Hands on Deck: A Focus on Current and Emerging Treatment Options in the Frontline Setting for Peripheral T-cell Lymphoma 41:21
  18. All Hands on Deck in Cervical Cancer Care: Screening, Treatment, and Equity Strategies to Improve Patient Lives 1:00:36
  19. All Hands on Deck – Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches 46:40
  20. Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team 1:18:19
  21. Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer 50:54
  22. Transforming Metastatic Breast Cancer Management: Harnessing the Power of Antibody-Drug Conjugate Therapies 1:33:21
  23. Navigating New Waters for Advanced or Recurrent Endometrial Cancer 1:06:48
  24. Cancer-Associated VTE: Balancing Risk and Reward with Modern Anticoagulation 50:27
  25. Actionable Strategies in Community Oncology to Achieve Equity in Triple-Negative Breast Cancer 54:13
  26. Primary Care Perspectives on Obesity: Embracing Novel Agents to Optimize Patient Outcomes 37:03
  27. Meeting Complex Challenges in Proteinuric Glomerular Disease: An Expert Review of Emerging Data and Novel Therapeutics for IgA Nephropathy 56:24
  28. Bridging Chasms in Bladder Cancer Care: An Expert Case-based Review of Treatment Selection and Sequencing in an Era of Therapeutic Novelty 1:30:56
  29. Nephrology Nursing Insights for Managing Chronic Kidney Disease–associated Pruritus: Embracing Evolving Data and Emerging Agents to Optimize Outcomes 41:04
  30. Navigating Novel Terrain in Anemia of Chronic Kidney Disease: A Patient-centric Review of Disease State, Current Chasms in Care, and the Future Promise of HIF-PH Inhibition 1:16:11
  31. Nephrology Nurse Viewpoints on In-hospital Hyperkalemia Management: Improving Patient Outcomes in Acute Care Settings with Novel Potassium Binders 57:39
  32. Harnessing the Power of Immunotherapy in HCC and BTC: An Expert Exploration of the Past, Present, and Future of Checkpoint Inhibition 1:02:45
  33. IV Iron Expert Exchange: Data-driven Debates on the Revolutionary Role of IV Iron in Heart Failure 1:36:50
  34. Pulmonology Perspectives on Biomarker Testing in NSCLC: Multidisciplinary Management in an Era of Rapid Change 1:47:28
  35. Optimizing Early Breast Cancer Outcomes in the Community Setting: An Expert Review of Emerging Therapies and Evolving Standards of Care in HR+/HER2- Disease 1:01:59
  36. Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treatment Paradigm 40:56
  37. Overcoming Pediatric Iron Deficiency Anemia with IV Iron: Interprofessional Approaches to Integrating New Data, Using Novel Agents, and Optimizing Care 53:32
  38. New Horizons in Unresectable Stage III NSCLC: A Case-based Exploration of Evolving Data and the Emergence of Immunotherapy 1:00:04
  39. Optimizing Cancer-related Anemia Outcomes in the Community Setting: Interprofessional Approaches and Evidence-supported Strategies for Improving Care with Intravenous Iron 49:32
  40. Breaking the Cycle in Cardiorenal Anemia Syndrome: The Practice-changing Role of IV Iron at the CKD–Heart Failure Interface 1:02:15
  41. 2022 EGFR+ Lung Cancer Rapid Recap: The Evolving State of the Science in EGFR+ NSCLC—A Closer Look at the Paradigm-Shifting Synergy of Safety, Efficacy, and Equitable Access 1:11:33
  42. Overcoming Disparity with Novelty in Triple-Negative Breast Cancer: Community Oncology Perspectives on Promoting Equity and Improving Clinical Outcomes 50:21
  43. Advancing Therapeutic Paradigms for Ovarian Cancer in The Era of PARP Inhibitors: A Guide for The Oncology Nurse 1:21:08
  44. Targeting Unmet Patient Needs in Diffuse Large B-Cell Lymphoma (DLBCL): Emerging Strategies for the Interprofessional Healthcare Team 47:17
  45. Interprofessional Perspectives on the Evolving Heart Failure Treatment Paradigm: Harnessing Novel Therapeutics to Optimize Outcomes & Overcome Disparities in Care 38:32
  46. Infusing Renewed Hope into Cancer-related Anemia with Intravenous Iron: An Expert-Led Exploration of Recent and Emerging Trial Data and Current Guideline Recommendations 46:27
  47. The Shot Heard 'Round the World: Vaccinating the Pandemic 33:32
  48. Restoring Normalcy via the Power of Immunology: Foundational Principles and Practical Questions 35:20
  49. COVID-19: What We Know About the Virus & the Disease 34:16